<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>About - BBB Project</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            line-height: 1.6;
            color: #333;
            background: #f5f5f5;
        }
        
        header {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 40px 20px;
            text-align: center;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
        }
        
        header h1 {
            font-size: 2.5em;
            margin-bottom: 10px;
        }
        
        nav {
            background: #2c3e50;
            padding: 15px 0;
            position: sticky;
            top: 0;
            z-index: 100;
            box-shadow: 0 2px 10px rgba(0,0,0,0.2);
        }
        
        nav ul {
            list-style: none;
            display: flex;
            justify-content: center;
            flex-wrap: wrap;
            gap: 30px;
        }
        
        nav a {
            color: white;
            text-decoration: none;
            font-weight: 600;
            padding: 8px 16px;
            border-radius: 5px;
            transition: background 0.3s;
        }
        
        nav a:hover {
            background: rgba(255,255,255,0.1);
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 40px 20px;
        }
        
        .section {
            background: white;
            margin-bottom: 40px;
            border-radius: 15px;
            padding: 40px;
            box-shadow: 0 5px 20px rgba(0,0,0,0.1);
        }
        
        .section h2 {
            color: #667eea;
            font-size: 2em;
            margin-bottom: 15px;
            padding-bottom: 10px;
            border-bottom: 3px solid #667eea;
        }
        
        .section h3 {
            color: #764ba2;
            font-size: 1.5em;
            margin-top: 25px;
            margin-bottom: 15px;
        }
        
        .section p {
            color: #555;
            font-size: 1.1em;
            line-height: 1.8;
            margin-bottom: 20px;
        }
        
        .team-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 30px;
            margin-top: 30px;
        }
        
        .team-member {
            background: linear-gradient(135deg, #667eea15 0%, #764ba215 100%);
            padding: 30px;
            border-radius: 15px;
            text-align: center;
            border: 2px solid #667eea;
        }
        
        .team-member h4 {
            color: #667eea;
            font-size: 1.3em;
            margin-bottom: 10px;
        }
        
        .figure-container {
            margin: 30px 0;
            text-align: center;
        }
        
        .figure-container img {
            max-width: 100%;
            height: auto;
            border-radius: 10px;
            box-shadow: 0 5px 15px rgba(0,0,0,0.1);
        }
        
        .figure-caption {
            margin-top: 15px;
            font-style: italic;
            color: #666;
            font-size: 0.95em;
        }
        
        .descriptors-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 25px;
            margin: 30px 0;
        }
        
        .descriptor-card {
            background: #f8f9fa;
            padding: 25px;
            border-radius: 10px;
            border-left: 5px solid #667eea;
        }
        
        .descriptor-card h4 {
            color: #667eea;
            margin-bottom: 10px;
            font-size: 1.2em;
        }
        
        .descriptor-card p {
            color: #666;
            font-size: 1em;
            margin-bottom: 0;
        }
        
        .methodology {
            background: #fff3cd;
            border-left: 5px solid #ffc107;
            padding: 25px;
            border-radius: 10px;
            margin: 30px 0;
        }
        
        .methodology h3 {
            color: #856404;
            margin-top: 0;
        }
        
        .methodology p, .methodology ul {
            color: #856404;
        }
        
        .methodology ul {
            margin-left: 20px;
            margin-top: 15px;
        }
        
        .methodology li {
            margin-bottom: 10px;
        }
        
        .highlight-box {
            background: linear-gradient(135deg, #667eea15 0%, #764ba215 100%);
            padding: 30px;
            border-radius: 15px;
            margin: 30px 0;
            border: 2px solid #667eea;
        }
        
        .equation {
            background: white;
            padding: 25px;
            border-radius: 10px;
            font-family: 'Courier New', monospace;
            font-size: 1.1em;
            margin: 20px 0;
            overflow-x: auto;
            border: 2px solid #e9ecef;
        }
        
        .reference {
            background: #e7f3ff;
            padding: 20px;
            border-radius: 10px;
            border-left: 5px solid #2196F3;
            margin: 30px 0;
        }
        
        .reference p {
            color: #0d47a1;
            font-size: 0.95em;
            margin-bottom: 0;
        }
        
        footer {
            background: #2c3e50;
            color: white;
            text-align: center;
            padding: 30px 20px;
            margin-top: 60px;
        }
    </style>
</head>
<body>
    <header>
        <h1>About the Project</h1>
        <p>Understanding Blood-Brain Barrier Drug Permeability</p>
    </header>
    
    <nav>
        <ul>
            <li><a href="index.html">Home</a></li>
            <li><a href="about.html">About</a></li>
            <li><a href="simulate.html">Interactive Simulator</a></li>
            <li><a href="viz.html">Data Visualizations</a></li>
            <li><a href="Final Project - Fixed Code (1).html">Full Analysis</a></li>
        </ul>
    </nav>
    
    <div class="container">
        <div class="section">
            <h2>Project Overview</h2>
            <p>The goal of this project is to analyze data regarding current drugs and their ability to cross the blood-brain barrier (BBB), with the eventual aim of creating an equation based on the analyzed data to generate a predictive model. This model is based on drugs which have the ability to cross the Blood-Brain Barrier and their chemical and physical properties.</p>
            
            <p>The information analyzed is used to generate a mathematical equation which can graphically determine a drug's ability to cross the BBB based on chosen molecular descriptors.</p>
            
            <div class="highlight-box">
                <h3>üéØ Project Goals</h3>
                <p><strong>Primary Objective:</strong> Develop a predictive model to determine whether a drug can cross the blood-brain barrier based on its molecular properties.</p>
                <p><strong>Secondary Objectives:</strong> Identify key molecular descriptors that influence BBB permeability and provide insights for drug design targeting central nervous system disorders.</p>
            </div>
        </div>
        
        <div class="section">
            <h2>Background Information</h2>
            
            <h3>What is the Blood-Brain Barrier?</h3>
            <p>The blood-brain barrier (BBB) is a highly selective semipermeable border of endothelial cells that prevents solutes in the circulating blood from non-selectively crossing into the extracellular fluid of the central nervous system where neurons reside. Understanding BBB permeability is crucial for developing drugs that treat neurological disorders such as Alzheimer's disease, Parkinson's disease, brain tumors, and epilepsy.</p>
            
            <h3>LogBB: The Key Metric</h3>
            <p>LogBB describes the concentration of a drug found on either side of the BBB. It is calculated as the logarithm of the ratio of drug concentration in the brain to drug concentration in the blood:</p>
            
            <div class="equation">
                LogBB = log‚ÇÅ‚ÇÄ(C<sub>brain</sub> / C<sub>blood</sub>)
            </div>
            
            <p>Where:</p>
            <ul style="margin-left: 40px; color: #555;">
                <li><strong>LogBB > 0:</strong> Higher concentration in brain than blood (good BBB penetration)</li>
                <li><strong>LogBB = 0:</strong> Equal concentration in brain and blood</li>
                <li><strong>LogBB < 0:</strong> Lower concentration in brain than blood (poor BBB penetration)</li>
            </ul>
        </div>
        
        <div class="section">
            <h2>Molecular Descriptors</h2>
            <p>We analyzed six key molecular descriptors that influence a drug's ability to cross the BBB. These descriptors were extracted using the RDKit package based on each molecule's SMILES formula (a computer-friendly chemical notation).</p>
            
            <div class="descriptors-grid">
                <div class="descriptor-card">
                    <h4>üíß Lipophilicity (MolLogP)</h4>
                    <p>Measures a compound's fat solubility. Higher lipophilicity generally improves membrane permeability, as the BBB is composed of lipid-rich cell membranes. Correlation with LogBB: +0.28</p>
                </div>
                
                <div class="descriptor-card">
                    <h4>‚öñÔ∏è Molecular Weight (MolWt)</h4>
                    <p>The mass of the molecule. Larger molecules have difficulty diffusing across biological membranes. Generally, drugs under 500 Da have better BBB penetration. Correlation with LogBB: -0.21</p>
                </div>
                
                <div class="descriptor-card">
                    <h4>üéØ Topological Polar Surface Area (TPSA)</h4>
                    <p>Measures the surface area occupied by polar atoms. Lower TPSA values (<90 ≈≤) are preferred for BBB penetration as they indicate less polarity. Strongest correlation with LogBB: -0.53</p>
                </div>
                
                <div class="descriptor-card">
                    <h4>‚ö° Formal Charge (FC)</h4>
                    <p>The net electrical charge on the molecule. Charged molecules have reduced membrane crossing ability due to the lipophilic nature of cell membranes. Correlation with LogBB: ~0.00</p>
                </div>
                
                <div class="descriptor-card">
                    <h4>üíç Aromatic Rings</h4>
                    <p>The number of aromatic ring structures in the molecule. While aromatic rings can improve stability, too many can increase molecular weight and reduce flexibility. Correlation with LogBB: -0.10</p>
                </div>
                
                <div class="descriptor-card">
                    <h4>üî¨ Heavy Atoms</h4>
                    <p>Non-hydrogen atoms in the molecule. Related to molecular weight, this descriptor influences the overall size and complexity of the drug molecule. Correlation with LogBB: -0.21</p>
                </div>
            </div>
            
            <div class="figure-container">
                <img src="Screenshot 2025-12-05 155136.png" alt="Correlation Analysis">
                <p class="figure-caption">Correlation matrix showing relationships between molecular descriptors and LogBB values.</p>
            </div>
        </div>
        
        <div class="section">
            <h2>Dataset</h2>
            <p>The dataset used in this project was sourced from the Blood-Brain Barrier Database (B3DB) on GitHub. It includes data on approximately 7,000 drugs and their ability to cross the BBB.</p>
            
            <p>Our analysis focused on a subset of approximately 1,000 drugs that have experimentally determined LogBB values, allowing us to build and validate predictive models with ground truth data.</p>
            
            <div class="reference">
                <p><strong>Data Source:</strong> F. Meng, Y. Xi, J. Huang, and P. W. Ayers, "A curated diverse molecular database of blood-brain barrier permeability with chemical descriptors," <em>Scientific Data</em>, vol. 8, no. 1, p. 289, Oct. 2021, doi: https://doi.org/10.1038/s41597-021-01069-5.</p>
            </div>
        </div>
        
        <div class="section">
            <h2>Methodology</h2>
            
            <div class="methodology">
                <h3>üìä Analysis Pipeline</h3>
                <p>Our computational approach consisted of several stages:</p>
                <ul>
                    <li><strong>Data Preparation:</strong> Cleaned the dataset and extracted molecular descriptors using RDKit</li>
                    <li><strong>Exploratory Analysis:</strong> Examined distributions and correlations between descriptors and LogBB</li>
                    <li><strong>Model Development:</strong> Built and compared multiple regression models</li>
                    <li><strong>Validation:</strong> Evaluated model performance using R¬≤ scores and prediction accuracy</li>
                    <li><strong>Simulation:</strong> Applied Fick's Law to model drug diffusion across the BBB</li>
                </ul>
            </div>
            
            <h3>Models Developed</h3>
            
            <div class="descriptors-grid">
                <div class="descriptor-card">
                    <h4>Multiple Linear Regression</h4>
                    <p>Combined all descriptors into a single model to predict LogBB values. Achieved R¬≤ = 0.333, explaining 33.3% of variance in BBB permeability.</p>
                </div>
                
                <div class="descriptor-card">
                    <h4>Logistic Regression</h4>
                    <p>Binary classification model to predict whether a drug crosses the BBB (LogBB > 0). Achieved 70.2% accuracy on test data.</p>
                </div>
                
                <div class="descriptor-card">
                    <h4>Gradient Boosting</h4>
                    <p>Advanced machine learning model using ensemble learning. Best performing model with R¬≤ = 0.357 and MAE = 0.437.</p>
                </div>
            </div>
            
            <div class="figure-container">
                <img src="download (1).png" alt="Model Performance">
                <p class="figure-caption">Multiple Linear Regression: Predicted vs Actual LogBB values showing model performance.</p>
            </div>
        </div>
        
        <div class="section">
            <h2>The Predictive Equation</h2>
            <p>Based on our multiple linear regression analysis, we developed the following equation to predict LogBB:</p>
            
            <div class="equation">
                <strong>LogBB</strong> = 0.2407 + (-0.0115 √ó MolLogP) + (-0.0013 √ó MolWt) + (-0.0133 √ó TPSA) + (0.0172 √ó FC) + (-0.1323 √ó Aromatic Rings) + (0.0512 √ó Heavy Atoms)
            </div>
            
            <p>Where a positive LogBB value (> 0) indicates the drug can effectively cross the blood-brain barrier. The brain-to-blood concentration ratio can be calculated as:</p>
            
            <div class="equation">
                K = 10<sup>LogBB</sup>
            </div>
            
            <div class="figure-container">
                <img src="download (2).png" alt="Regression Coefficients">
                <p class="figure-caption">Confusion Matrix of Logistic Regression Accuracy.</p>
            </div>
        </div>
        
        <div class="section">
            <h2>Key Findings</h2>
            
            <div class="highlight-box">
                <h3>üîç Most Important Factors</h3>
                <p><strong>TPSA</strong> showed the strongest correlation with BBB permeability (-0.53), indicating that polar surface area is the most critical factor. Drugs with TPSA < 90 ≈≤ generally show better BBB penetration.</p>
                
                <p><strong>Lipophilicity (MolLogP)</strong> showed a positive correlation (+0.28), confirming that more lipophilic drugs cross the BBB more readily, though excessive lipophilicity can cause other issues.</p>
                
                <p><strong>Aromatic Rings</strong> had a negative coefficient (-0.13), suggesting that reducing aromatic ring count can improve BBB permeability while maintaining drug efficacy.</p>
            </div>
            
            <div class="figure-container">
                <img src="download (3).png" alt="Feature Importance">
                <p class="figure-caption">Feature importance from Gradient Boosting model showing which descriptors are most influential in predictions.</p>
            </div>
            
            <h3>Implications for Drug Design</h3>
            <p>Our findings suggest that for improved BBB penetration, drug candidates should be designed with:</p>
            <ul style="margin-left: 40px; color: #555;">
                <li>Lower topological polar surface area (TPSA < 90 ≈≤)</li>
                <li>Moderate lipophilicity (MolLogP between 1-3)</li>
                <li>Molecular weight under 500 Da</li>
                <li>Minimal formal charge (neutral molecules preferred)</li>
                <li>Reduced number of aromatic rings</li>
            </ul>
        </div>
    </div>
    
    <footer>
        <p>&copy; 2025 Team ALEX - BBB Computational Modeling Project</p>
        <p>Alex Luna, Alex Dhupar, Alexis Guth</p>
    </footer>
</body>
</html>
